Bicara Therapeutics Inc. Share Price
NASDAQ: BCAX | Mega CapBicara Therapeutics Inc. Stock Performance
Bicara Therapeutics Inc. Share Price Today
As of 1 November 2026, Bicara Therapeutics Inc.'s share price is $9.12. The stock opened at $9.20, compared to its previous close of $9.68. During today's trading session, Bicara Therapeutics Inc.'s share price traded between $8.42 and $9.27, with an average price of $8.84. Over the past 52 weeks, the stock has recorded a high of $30.93 and a low of $8.42. In terms of performance, Bicara Therapeutics Inc.'s share price has declined by 57.84% over the last six months and is down 43.86% on a year-on-year basis.
Bicara Therapeutics Inc. Share Price Chart
Bicara Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Bicara Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Bicara Therapeutics Inc.
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.
Bicara Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $19.05 | $9.04 | -51.48% |
Sep 2026 | $22.73 | $18.64 | -24.90% |
Aug 2026 | $26.24 | $24.82 | -8.41% |
Jul 2026 | $29.55 | $27.10 | -8.69% |
Jun 2026 | $21.02 | $29.68 | +36.52% |
May 2026 | $21.57 | $21.74 | +0.51% |
Apr 2026 | $20.14 | $21.63 | +8.83% |
Mar 2026 | $16.43 | $19.88 | +18.30% |
Feb 2026 | $17.00 | $16.80 | +0.00% |
Jan 2026 | $16.50 | $16.80 | -0.12% |
Dec 2025 | $17.82 | $16.82 | -9.28% |
Nov 2025 | $15.87 | $18.54 | +14.13% |